Type-1 interferons regulate immune responses and the production of self-reactive antibodies that target red blood cells in a SCD mouse model.

HDFN has affected 2 of Andrea Renzi's 5 children and turned her into an activist on behalf of other mothers and families touched by the disease.

Explore AC Immune's innovative Alzheimer's and Parkinson's therapies, key pharma collaborations, and financial outlook. Learn more on ACIU stock here.

Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.

Another antibody drug conjugate disitamab vedotin (an anti-HER2 antibody drug conjugate with MMAE payload) has also been shown to potentially pair well with immunotherapy. Disitamab vedotin + ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...

NT219, a novel agent designed to overcome tumor resistance to drug therapy, will be evaluated in combination with the standard-of-care head and ...

Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...

A study published in December by Duke professor Rohit Singh and his team proposes a new computational model called antibody ...

Robert F. Kennedy Jr., President Trump's new head of the Department of Health and Human Services, has raised doubts about vaccines — but history shows they've saved millions of lives.